Pat LePore
Chairman chez PAR PHARMACEUTICAL COMPANIES, INC.
Fortune : 115 639 $ au 31/05/2023
Postes actifs de Pat LePore
Sociétés | Poste | Début | Fin |
---|---|---|---|
PAR PHARMACEUTICAL COMPANIES, INC. | Chairman | - | - |
VYNE THERAPEUTICS INC. | Director/Board Member | 10/09/2020 | - |
Independent Dir/Board Member | 10/09/2020 | - | |
Villanova University | Director/Board Member | - | - |
Tyme, Inc.
Tyme, Inc. BiotechnologyHealth Technology Part of Syros Pharmaceuticals, Inc., Tyme, Inc. is a private company that provides research and development services focused on developing drug candidates for the treatment of cancer. The company is based in Wilmington, DE. Steve Hoffman has been the CEO of the company since 2013. Tyme was acquired by Tyme Technologies, Inc., part of Syros Pharmaceuticals, Inc. from September 19, 2022 on March 05, 2015. | Director/Board Member | 05/05/2015 | - |
Lautus Pharmaceuticals LLC
Lautus Pharmaceuticals LLC Household/Personal CareConsumer Non-Durables Lautus Pharmaceuticals LLC engages in the manufacture and sale of cosmetic products. The company was founded in 2013 and is headquartered in Summit, NJ. | Chairman | 01/01/2013 | - |
Historique de carrière de Pat LePore
Anciens postes connus de Pat LePore
Sociétés | Poste | Début | Fin |
---|---|---|---|
LANNETT COMPANY, INC. | Director/Board Member | 01/07/2017 | 01/07/2018 |
Chairman | 01/07/2018 | 16/06/2023 | |
Independent Dir/Board Member | 01/07/2017 | 16/06/2023 | |
MATINAS BIOPHARMA HOLDINGS, INC. | Director/Board Member | 05/09/2018 | 01/11/2021 |
Independent Dir/Board Member | 05/09/2018 | 01/11/2021 | |
INNOVIVA, INC. | Director/Board Member | 27/10/2016 | 24/04/2018 |
Independent Dir/Board Member | 27/10/2016 | 24/04/2018 | |
PHARMERICA CORPORATION | Director/Board Member | 14/01/2013 | 07/12/2017 |
Independent Dir/Board Member | 14/01/2013 | 07/12/2017 | |
░░░ ░░░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░ ░░░░░░ ░ ░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - | |
░░░░░░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ | - |
Formation de Pat LePore
Fairleigh Dickinson University | Masters Business Admin |
Villanova University | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 15 |
2 |
Opérationnelle
Director/Board Member | 8 |
Chairman | 6 |
Independent Dir/Board Member | 6 |
Sectorielle
Health Technology | 9 |
Consumer Services | 3 |
Distribution Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 4 |
---|---|
CARDINAL HEALTH, INC. | Distribution Services |
LANNETT COMPANY, INC. | Health Technology |
MATINAS BIOPHARMA HOLDINGS, INC. | Health Technology |
INNOVIVA, INC. | Health Technology |
Entreprise privées | 9 |
---|---|
Endo Generics Holdings, Inc.
Endo Generics Holdings, Inc. Pharmaceuticals: GenericHealth Technology Endo Generics Holdings, Inc. develops, manufactures, and markets generic pharmaceutical products. It also offers dosage, branded, and generic sterile injectable products. The company was founded in 1978 and is headquartered in New York, NY. | Health Technology |
Boron, LePore & Associates, Inc.
Boron, LePore & Associates, Inc. Miscellaneous Commercial ServicesCommercial Services Boron, LePore & Associates, Inc. provides integrated medical education to the healthcare industry. It provides strategic consultation, content development, accredited & non-accredited program development, logistics management and other internet-based solutions. The company was founded in 1981 and is headquartered in Wayne, NJ. | Commercial Services |
AgeneBio, Inc.
AgeneBio, Inc. BiotechnologyHealth Technology AgeneBio, Inc. develops an innovative therapeutics for unserved patients afflicted with neurological and psychiatric diseases to preserve and restore brain function. It research focused on cognitive neuroscience and the neurobiology of the aging brain with most advanced clinical program targets amnestic mild cognitive impairment (aMCI), the symptomatic, pre-dementia stage of Alzheimer’s. The company was founded by Michela Gallagher in 2008 and is headquartered in Baltimore, MD. | Health Technology |
Tyme Technologies, Inc.
Tyme Technologies, Inc. Pharmaceuticals: MajorHealth Technology Tyme Technologies, Inc. operates as a biotechnology company, which engages in the development and commercialization of cancer therapies. It offers a clinical program named SM-88 which is a novel, oral, and monotherapy investigational agent that aims to disrupt the cancer cell's protein synthesis. The company was founded by Steve Hoffman and Michael Demurjian on November 22, 2011 and is headquartered in Bedminster, NJ. | Health Technology |
Par Pharmaceutical, Inc.
Par Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Par Pharmaceutical, Inc. manufactures and markets generic drugs and pharmaceuticals products. It produces drugs for hypertension, inflammation, depression and pain. The firm distributes its products in the semi-solid form of a cream. The company was founded in 1978 and is headquartered in Chestnut Ridge, NY. | Health Technology |
PharMerica Corp.
PharMerica Corp. Drugstore ChainsRetail Trade PharMerica Corp. operates as an institutional pharmacy service company. The firm operates through following segments: Institutional Pharmacy, Specialty Infusion Services, and Specialty Oncology Pharmacy. The company was founded in 2006 and is headquartered in Louisville, KY. | Retail Trade |
Tyme, Inc.
Tyme, Inc. BiotechnologyHealth Technology Part of Syros Pharmaceuticals, Inc., Tyme, Inc. is a private company that provides research and development services focused on developing drug candidates for the treatment of cancer. The company is based in Wilmington, DE. Steve Hoffman has been the CEO of the company since 2013. Tyme was acquired by Tyme Technologies, Inc., part of Syros Pharmaceuticals, Inc. from September 19, 2022 on March 05, 2015. | Health Technology |
Lautus Pharmaceuticals LLC
Lautus Pharmaceuticals LLC Household/Personal CareConsumer Non-Durables Lautus Pharmaceuticals LLC engages in the manufacture and sale of cosmetic products. The company was founded in 2013 and is headquartered in Summit, NJ. | Consumer Non-Durables |
VYNE Therapeutics, Inc. |
- Bourse
- Insiders
- Pat LePore
- Expérience